The offerings of the company are able to deliver more accurate test results compared to other competing brands. Because their products do not use any adapters, it eliminates additional dead space that would potentially create a leak during the testing process. This feature is one of the highlights of the offerings of the company that are not available in competing businesses. The validated test results of the business are meeting the standards set by ATS and ERS. These offerings are used in non-invasive cardiorespiratory diagnostic procedures.
Their main products are pulmonary function (PFT) and gas exchange (GX) testing products. These offerings are supported by their world class supplies that enhance the accuracy of every testing procedure conducted using their machines. These devices are used to detect diseases, integrate care and wellness across the entire cardiorespiratory healthcare system. They are intended to measure and analyze airflow, respiratory pressures and the presence of gas such as oxygen and carbon dioxide. The dedication of the company in providing cardiorespiratory health solutions is backed by years of research conducted by the business and other third parties.
It is in Saint Paul, Minnesota that the business holds its headquarters. As a global medical technology company, it markets its products internationally through their networks of distributors. These devices are usually found in clinics and hospitals and other emergency care facilities. MGC Diagnostics Corporation remains to be publicly traded on the NASDAQ Capital Market. Its common shares are marketed using the ticker symbol MGCD.